| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.0M | +17.8% |
| Cost of Revenue | $14.3M | +16.4% |
| Gross Profit | $22.7M | +18.7% |
| R&D Expense | $13.9M | +12.1% |
| SG&A Expense | $16.5M | +37.5% |
| Operating Income | -$24.2M | -22.4% |
| Pre-tax Income | -$25.5M | -34.8% |
| Income Tax | $55K | +358.3% |
| Net Income | -$25.5M | -35.0% |
| EPS (Basic) | -$0.90 | -28.6% |
| EPS (Diluted) | -$0.90 | -28.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.9M | +128.4% |
| Accounts Receivable | $6.5M | +39.0% |
| Inventory | $8.4M | +21.8% |
| Current Assets | $63.6M | +90.6% |
| Total Assets | $97.7M | +149.4% |
| Current Liabilities | $10.8M | +4.0% |
| Long-term Debt | $49.1M | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.9M | -167.3% |
| Capital Expenditures | $522K | +89.8% |
| Investing Cash Flow | $615K | +323.6% |
| Financing Cash Flow | $50.2M | +710.8% |
| Free Cash Flow | -$24.4M | -165.0% |
| $69.7M |
| +405.3% |
| Stockholders' Equity | $28.0M | +10.4% |